FILE PHOTO: Small bottles labeled with a “Vaccine COVID-19” sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – The Trump administration has selected five companies as the most likely candidates to produce a vaccine for the coronavirus, the New York Times reported on Wednesday, citing senior officials.
The five companies are Moderna, the combination of Oxford University and AstraZeneca Plc, Johnson & Johnson, Merck & Co Inc and Pfizer Inc, according to the paper.
Reporting by Ankur Banerjee in Bengaluru; Editing by Anil D’Silva
Our Standards:The Thomson Reuters Trust Principles.
This article was originally published by Reuters.com. Read the original article here.